Financial Benchmarking: Report uses GlobalData’s proprietary benchmarking methodology to rank 15 innovative biotech companies on 20 different financial metrics
Pipeline analysis: Tracks pipeline advancements and drug approvals across this peer group over the past 12 months
Licensing & Acquisition Strategies: Deep discussion on the strategic implications and synergies of recent M&A and deals activity
Resource Management Strategies: New section created to discuss and analyze the operations and firm utilization of these innovative biotech companies.
Expert Insight on the corporate strategies of these mid-cap biotech companies seeking a competitive advantage in the pharmaceuticals market place
Revenue Forecasts: New analysis providing top-line revenue forecast for each company for next six months.
Receive free alerts when new cardiovascular research is released.
Report can be used by individual purchaser only.
Report can be shared by unlimited users within one corporate location,
e.g. a regional office.
Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.
Call us on +44 1204 543 529
Get one-to-one support from our expert analysts only when you buy direct
You will not find our reports cheaper anywhere else
Our client support team are on-hand to assist with your research needs
700+ analysts delivering actionable insight